← Evidence map

ArticleDermatology and therapy2025

Efficacy and Safety of Apremilast Over 52 Weeks in Patients with Plaque Psoriasis in High-Impact Areas and Impaired Quality of Life.

Matthias Augustin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40317400